Annual Current Liabilities
$12.32 M
+$4.49 M+57.26%
December 31, 2023
Summary
- As of February 7, 2025, PBLA annual total current liabilities is $12.32 million, with the most recent change of +$4.49 million (+57.26%) on December 31, 2023.
- During the last 3 years, PBLA annual current liabilities has risen by +$10.95 million (+802.42%).
- PBLA annual current liabilities is now at all-time high.
Performance
PBLA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$20.14 M
+$3.35 M+19.98%
September 30, 2024
Summary
- As of February 7, 2025, PBLA quarterly total current liabilities is $20.14 million, with the most recent change of +$3.35 million (+19.98%) on September 30, 2024.
- Over the past year, PBLA quarterly current liabilities has increased by +$7.82 million (+63.52%).
- PBLA quarterly current liabilities is now at all-time high.
Performance
PBLA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PBLA Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +57.3% | +63.5% |
3 y3 years | +802.4% | +106.7% |
5 y5 years | +655.7% | +106.7% |
PBLA Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +363.1% | at high | +657.2% |
5 y | 5-year | at high | +802.4% | at high | +1437.6% |
alltime | all time | at high | +2537.7% | at high | +4213.1% |
Panbela Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $20.14 M(+20.0%) |
Jun 2024 | - | $16.79 M(+59.6%) |
Mar 2024 | - | $10.52 M(-14.6%) |
Dec 2023 | $12.32 M(+57.3%) | $12.32 M(+38.1%) |
Sep 2023 | - | $8.92 M(-15.5%) |
Jun 2023 | - | $10.55 M(+8.3%) |
Mar 2023 | - | $9.75 M(+24.4%) |
Dec 2022 | $7.83 M(+194.5%) | $7.83 M(-1.5%) |
Sep 2022 | - | $7.95 M(+28.2%) |
Jun 2022 | - | $6.20 M(+37.6%) |
Mar 2022 | - | $4.51 M(+69.4%) |
Dec 2021 | $2.66 M(+94.9%) | $2.66 M(+98.7%) |
Sep 2021 | - | $1.34 M(-3.9%) |
Jun 2021 | - | $1.39 M(+6.3%) |
Mar 2021 | - | $1.31 M(-4.0%) |
Dec 2020 | $1.36 M(-22.4%) | $1.36 M(-29.5%) |
Sep 2020 | - | $1.94 M(+12.5%) |
Jun 2020 | - | $1.72 M(+21.9%) |
Mar 2020 | - | $1.41 M(-19.7%) |
Dec 2019 | $1.76 M(+7.9%) | $1.76 M(+155.3%) |
Sep 2019 | - | $689.00 K(-3.5%) |
Jun 2019 | - | $714.00 K(-71.4%) |
Mar 2019 | - | $2.50 M(+53.3%) |
Dec 2018 | $1.63 M | $1.63 M(+9.6%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2018 | - | $1.49 M(+3.2%) |
Jun 2018 | - | $1.44 M(-63.0%) |
Mar 2018 | - | $3.90 M(-6.6%) |
Dec 2017 | $4.17 M(-24.4%) | $4.17 M(+94.0%) |
Sep 2017 | - | $2.15 M(+1.5%) |
Jun 2017 | - | $2.12 M(-12.6%) |
Mar 2017 | - | $2.42 M(-56.1%) |
Dec 2016 | $5.52 M(+301.4%) | $5.52 M(+165.1%) |
Sep 2016 | - | $2.08 M(+20.7%) |
Jun 2016 | - | $1.73 M(-9.6%) |
Mar 2016 | - | $1.91 M(+38.8%) |
Dec 2015 | $1.38 M(+194.4%) | $1.38 M(+49.6%) |
Sep 2015 | - | $919.00 K(+61.6%) |
Jun 2015 | - | $568.80 K(-11.3%) |
Mar 2015 | - | $641.00 K(+37.3%) |
Dec 2014 | $467.00 K(-29.6%) | $467.00 K(-30.3%) |
Sep 2014 | - | $669.90 K(+0.5%) |
Jun 2014 | - | $666.80 K(-1.4%) |
Mar 2014 | - | $676.10 K(+1.9%) |
Dec 2013 | $663.70 K(+3.1%) | $663.70 K(+1.5%) |
Sep 2013 | - | $653.60 K(+1.1%) |
Jun 2013 | - | $646.40 K(-0.9%) |
Mar 2013 | - | $652.00 K(+1.3%) |
Dec 2012 | $643.50 K(-1.7%) | $643.50 K |
Dec 2011 | $654.90 K | - |
FAQ
- What is Panbela Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Panbela Therapeutics?
- What is Panbela Therapeutics annual current liabilities year-on-year change?
- What is Panbela Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly current liabilities year-on-year change?
What is Panbela Therapeutics annual total current liabilities?
The current annual current liabilities of PBLA is $12.32 M
What is the all time high annual current liabilities for Panbela Therapeutics?
Panbela Therapeutics all-time high annual total current liabilities is $12.32 M
What is Panbela Therapeutics annual current liabilities year-on-year change?
Over the past year, PBLA annual total current liabilities has changed by +$4.49 M (+57.26%)
What is Panbela Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of PBLA is $20.14 M
What is the all time high quarterly current liabilities for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly total current liabilities is $20.14 M
What is Panbela Therapeutics quarterly current liabilities year-on-year change?
Over the past year, PBLA quarterly total current liabilities has changed by +$7.82 M (+63.52%)